Pays: États-Unis
Langue: anglais
Source: NLM (National Library of Medicine)
GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ)
NCS HealthCare of KY, Inc dba Vangard Labs
GUAIFENESIN
GUAIFENESIN 600 mg
ORAL
OTC DRUG
Expectorant helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
Abbreviated New Drug Application
GUAIFENESIN EXTENDED RELEASE EXTENDED RELEASE- GUAIFENESIN TABLET, EXTENDED RELEASE NCS HEALTHCARE OF KY, INC DBA VANGARD LABS ---------- GUAIFENESIN ER TABS ACTIVE INGREDIENT (IN EACH EXTENDED-RELEASE TABLET) Guaifenesin 600 mg PURPOS E Expectorant US ES helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive WARNINGS DO NOT USE for children under 12 years of age ASK A DOCTOR BEFORE USE IF YOU HAVE persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema cough accompanied by too much phlegm (mucus) STOP USE AND ASK A DOCTOR IF cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness. IF PREGNANT OR BREAST-FEEDING, ask a health professional before use. KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222) DIRECTIONS do not crush, chew, or break tablet take with a full glass of water this product can be administered without regard for the timing of meals adults and children 12 years of age and over: one or two tablets every 12 hours. Do not exceed 4 tablets in 24 hours. children under 12 years of age: do not use OTHER INFORMATION do not use if printed seal under cap is broken or missing store between 20-25°C (68-77°F) INACTIVE INGREDIENTS compressible sugar, copovidone, hydroxyethyl cellulose, silicon dioxide, zinc stearate QUESTIONS OR COMMENTS? 1-800-719-9260 Distributed by Perrigo Allegan, MI 49010 www.perrigo.com 49878 RT F3 PACKAGE/LABEL PRINCIPAL DISPLAY PANEL GUAIFENESIN EXTENDED RELEASE EXTENDED RELEASE guaifenesin tablet, extended release PRODUCT INFORMATION PRODUCT T YPE HUMAN OTC DRUG ITE M CODE (SOURCE ) NDC:0 6 15-7712(NDC:458 0 2-49 8 ) ® NCS HealthCare of KY, Inc dba Vangard Labs ROUTE OF ADMINISTRATION ORAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH GUAIFENESIN (UNII: 49 5W7451VQ) Lire le document complet